Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-23T15:02:25.307Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of high dose antipsychotic medication

Published online by Cambridge University Press:  02 January 2018

Graeme Yorston  and
Alison Pinney
Graeme Yorston*
Affiliation:
DMHE Community Team, South Buckinghamshire NHS Trust, Shrubbery Road, High Wycombe, Buckinghamshire HP13 6PS
Alison Pinney
Affiliation:
Amersham Hospital, Whielden Street, Amersham, Bucks HP7 0JD
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

An audit of antipsychotic prescribing was carried out on community and in-patient samples. A novel method of expressing total daily antipsychotic dose as a percentage of the British National Formulary maximum recommended dose was used. Of 226 patients who had been prescribed antipsychotics, 16 (7%) were found to be on high closes. Their medical notes were examined to ascertain whether the Royal College of Psychiatrists guidelines were being followed. Recommendations on ways in which practice could be improved were made and a re-audit was carried out. The number of patients receiving high doses fell to 6 (3%) out of 206.

Type
Audit
Information
Psychiatric Bulletin , Volume 21 , Issue 9 , September 1997 , pp. 566 - 569
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

Dewan, M. J. & Koss, M. (1995) The clinical impact of reported variance in potency of antipsychotic agents. Acta Psychiatrica Scandinavica, 91, 229–232.Google Scholar
Krasucki, C. & McFarlane, F. (1996) Electrocardiograms. high-dose antipsychotic treatment and College guidelines. Psychiatric Bulletin, 20, 326–330.CrossRefGoogle Scholar
Mehtonen, O. P., Aranko, K., Malkonen, L., et al (1991) A study of sudden death associated with the use of antipsychotic or antidepressant drugs. Acta Psychiatrica Scandinavica, 84, 58–64.Google Scholar
Milton, J., Lawton, J. & Buckley, A. (1995) Neuroleptic prescribing practice. Psychiatric Bulletin, 19, 575–576.Google Scholar
Morgan, J., Haw, C. & Angier, L. (1996) Audit of inpatient neuroleptic prescribing. Auditorium, 5, 46–48.Google Scholar
Sellu, D. (1996) Time to audit audit. British Medical Journal, 312, 128–129.Google Scholar
Thompson, C. (1994) The use of high-dose antipsychotic medication. Consensus statement. British Journal of Psychiatry, 164, 448–458.CrossRefGoogle Scholar
Warner, J., Slade, R. & Barnes, T. (1995) Change in neuroleptic prescribing practice. Psychiatric Bulletin, 19, 237–339.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.